FDA
approval
· 2017-12-19
FDA Approved: SEGLUROMET — Original Application (Merck Sharp & Dohme LLC)
Summary
FDA approved Segluromet (ertugliflozin and metformin hydrochloride) under an original application by Merck Sharp & Dohme LLC for the treatment of type 2 diabete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SEGLUROMET (ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE)